These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26354758)

  • 1. Hyaluronic acid concentration in liver diseases.
    Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Flisiak R; Świderska M; Szmitkowski M; Chrostek L
    Clin Exp Med; 2016 Nov; 16(4):523-528. PubMed ID: 26354758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 Concentration in Liver Diseases.
    Gudowska M; Gruszewska E; Cylwik B; Panasiuk A; Rogalska M; Flisiak R; Szmitkowski M; Chrostek L
    Ann Clin Lab Sci; 2015; 45(6):669-73. PubMed ID: 26663797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis.
    Malik R; Lai M; Sadiq A; Farnan R; Mehta S; Nasser I; Challies T; Schuppan D; Afdhal N
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1562-8. PubMed ID: 20796156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis.
    Rossi E; Adams LA; Ching HL; Bulsara M; MacQuillan GC; Jeffrey GP
    Clin Chem Lab Med; 2013 May; 51(5):1107-14. PubMed ID: 23152415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
    Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changed Profile of Serum Transferrin Isoforms in Liver Diseases.
    Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Swiderska M; Filisiak R; Szmitkowski M; Chrostek L
    Clin Lab; 2017 Feb; 63(2):349-354. PubMed ID: 28182352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hyaluronic acid as a marker of hepatic fibrosis.
    Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
    Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of FibroTest and hyaluronic acid biological variation in healthy volunteers and comparison of serum hyaluronic acid biological variation between chronic liver diseases of different etiology and fibrotic stage using confidence intervals.
    Istaces N; Gulbis B
    Clin Biochem; 2015 Jul; 48(10-11):652-7. PubMed ID: 25863110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    Suzuki A; Angulo P; Lymp J; Li D; Satomura S; Lindor K
    Liver Int; 2005 Aug; 25(4):779-86. PubMed ID: 15998429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseases.
    Gudowska-Sawczuk M; Wrona A; Gruszewska E; Cylwik B; Panasiuk A; Flisiak R; Chrostek L
    Scand J Clin Lab Invest; 2018; 78(1-2):125-130. PubMed ID: 29272979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.
    McHutchison JG; Blatt LM; de Medina M; Craig JR; Conrad A; Schiff ER; Tong MJ
    J Gastroenterol Hepatol; 2000 Aug; 15(8):945-51. PubMed ID: 11022838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
    Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
    Kaneda H; Hashimoto E; Yatsuji S; Tokushige K; Shiratori K
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
    Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
    Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.